RW
PFE icon

Rand Wealth’s Pfizer PFE Stock Holding History

Rand Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$9.49M Sell
226,948
-3,129
-1% -$120K 1.06% 23
2018
Q2 		$7.92M Sell
230,077
-26,664
-10% -$911K 0.88% 30
2018
Q1 		$8.64M Sell
256,741
-479
-0.2% -$16.5K 0.97% 28
2017
Q4 		$8.84M Buy
257,220
+1,994
+0.8% +$68K 0.97% 28
2017
Q3 		$8.64M Buy
255,226
+1,071
+0.4% +$34.4K 1% 27
2017
Q2 		$8.1M Sell
254,155
-17,468
-6% -$551K 1.1% 23
2017
Q1 		$8.82M Sell
271,623
-3,433
-1% -$108K 1.06% 23
2016
Q4 		$8.48M Sell
275,056
-787
-0.3% -$24K 1.07% 27
2016
Q3 		$8.86M Buy
275,843
+7,578
+3% +$253K 1.16% 25
2016
Q2 		$8.96M Buy
268,265
+57,755
+27% +$1.84M 1.21% 21
2016
Q1 		$5.92M Buy
210,510
+2,241
+1% +$64K 0.82% 38
2015
Q4 		$6.38M Sell
208,269
-5,687
-3% -$179K 0.9% 33
2015
Q3 		$6.38M Buy
213,956
+904
+0.4% +$29K 0.93% 31
2015
Q2 		$6.78M Sell
213,052
-4,078
-2% -$133K 0.92% 31
2015
Q1 		$7.17M Buy
217,130
+4,145
+2% +$132K 0.96% 27
2014
Q4 		$6.63M Buy
212,985
+4,688
+2% +$134K 0.91% 29
2014
Q3 		$5.84M Sell
208,297
-44,972
-18% -$1.26M 0.85% 32
2014
Q2 		$7.13M Sell
253,269
-2,536
-1% -$72.3K 1.02% 28
2014
Q1 		$7.79M Buy
255,805
+1,950
+0.8% +$58.1K 1.35% 21
2013
Q4 		$7.38M Buy
253,855
+4,975
+2% +$145K 1.31% 23
2013
Q3 		$6.78M Sell
248,880
-646
-0.3% -$17.6K 1.34% 21
2013
Q2 		$6.63M Buy
+249,526
New +$6.89M 1.45% 19

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rand Wealth's PFE Position: Q3 2018 in Review

Rand Wealth reduced its Pfizer (PFE) stake by 1.4% in Q3 2018, selling an estimated $120K and leaving 226,948 shares worth $9.49M. The position accounts for 1.06% of the portfolio, ranked #23.

Rand Wealth first reported a position in PFE in Q2 2013 and has held it in 22 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

  • Rand Wealth held 226,948 shares of Pfizer worth $9.49M as of Q3 2018.
  • Rand Wealth sold 3,129 Pfizer shares in Q3 2018, an estimated $120K.
  • Pfizer made up 1.06% of Rand Wealth's portfolio in Q3 2018, its #23 holding.
  • Rand Wealth first reported a position in Pfizer in Q2 2013 and has held it in 22 quarters since.
  • 2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Rand Wealth's 13F filing for Q3 2018, filed 13 Nov 2018.